Study describes monkeypox in women; CDC warns of Tpoxx resistance
Por um escritor misterioso
Descrição
Unusual global outbreak of monkeypox: what should we do?
Tecovirimat Safe in Monkeypox, but Efficacy Is Less Clear
Monkeypox Virus Infections in Humans
Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022
Low risk of monkeypox spread noted in health workers
TPoxx antiviral should only be given to high-risk monkeypox patients, CDC says - The Washington Post
TPoxx antiviral should only be given to high-risk monkeypox patients, CDC says - The Washington Post
Technical Report 3: Multi-National Mpox Outbreak, United States, 2022, Mpox, Poxvirus
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate
Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission - ScienceDirect
Healthcare, Free Full-Text
Cureus, A Narrative Review on the Monkeypox Virus: An Ongoing Global Outbreak Hitting the Non-Endemic Countries
The CDC Domestic Mpox Response — United States, 2022–2023
:max_bytes(150000):strip_icc()/GettyImages-1407058659-37684722f3204a3f8e1aa8fe6eb94250.jpg)
